|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/196 | |
| A61P 3/06 |
| (11) | Number of the document | 2736505 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12820828.7 |
| Date of filing the European patent application | 2012-07-13 | |
| (97) | Date of publication of the European application | 2014-06-04 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE2012/050835 |
| Date | 2012-07-13 |
| (87) | Number | WO 2013/019156 |
| Date | 2013-02-07 |
| (30) | Number | Date | Country code |
| 1150728 | 2011-07-29 | SE |
| (72) |
KETELHUTH, Daniel, SE
|
| (73) |
Hansson, Göran K.,
St. Eriksgatan 14, 112 39 Stockholm,
SE
|
| (54) | 3-HYDROXYANTHRANILIC ACID (3-HAA) THERAPY FOR PREVENTION AND TREATMENT OF HYPERLIPIDEMIA AND ITS CARDIOVASCULAR COMPLICATIONS |
| 3-HYDROXYANTHRANILIC ACID (3-HAA) THERAPY FOR PREVENTION AND TREATMENT OF HYPERLIPIDEMIA AND ITS CARDIOVASCULAR COMPLICATIONS |